title: Prognostic impact of dissected lymph node count on patients with node-negative gastric cancer.
abstract: OBJECTIVE
  To investigate the long-term effect of the number of resected lymph nodes (LNs) on the prognosis of patients with node-negative gastric cancer.
  
  
  METHODS
  Clinical data of 211 patients with gastric cancer, without nodal involvement, were analyzed retrospectively after D2 radical operation. We analyzed the relationship between the number of resected LNs with the 5-year survival, the recurrence rate and the post-operative complication rate.
  
  
  RESULTS
  The 5-year survival of the entire cohort was 82.2%. The total number of dissected LNs was one of the independent prognostic factors. Among patients with comparable depth of invasion, the larger the number of resected LNs, the better the survival (P < 0.05). A cut-point analysis provided the possibility to detect a significant survival difference among subgroups. Patients had a better long-term survival outcomes with LN counts > or = 15 for pT1-2, > or = 20 for pT3-4, and > or = 15 for the entire cohort. The overall recurrence rate was 29.4% within 5 years after surgery. There was a statistically significant, negative correlation between the number of resected LNs and the recurrence rate (P < 0.01). The post-operative complication rate was 10.9% and was not significantly correlated with the number of dissected LNs (P > 0.05).
  
  
  CONCLUSIONS
  For node-negative gastric cancer, sufficient number of dissected LNs is recommended during D2 lymphadenectomy, to improve the long-term survival and reduce the recurrence. Suitable increments of the dissected LN count would not increase the post-operative complication rate.
authors.affiliation: Department of Oncology, Affiliated Union Hospital, Fujian Medical University, No. 29 Xinquan Road, Fuzhou 350001, Fujian Province, China. hcmlr253@sohu.com
authors.forename: Chang-Ming
authors.initials: CM
authors.lastname: Huang
authors.forename: Jian-Xian
authors.initials: JX
authors.lastname: Lin
authors.forename: Chao-Hui
authors.initials: CH
authors.lastname: Zheng
authors.forename: Ping
authors.initials: P
authors.lastname: Li
authors.forename: Jian-Wei
authors.initials: JW
authors.lastname: Xie
authors.forename: Bi-Juan
authors.initials: BJ
authors.lastname: Lin
authors.forename: Hui-Shan
authors.initials: HS
authors.lastname: Lu
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D008198:Lymph Nodes / Q000473:pathology / Q000601:surgery; D008207:Lymphatic Metastasis / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000473:pathology; D011183:Postoperative Complications; D011379:Prognosis; D012189:Retrospective Studies; D013274:Stomach Neoplasms / Q000473:pathology / Q000601:surgery; D015996:Survival Rate; D016896:Treatment Outcome
references.citation: Ann Surg. 2000 Sep;232(3):362-71
references.pmid: 10973386
references.citation: Ann Surg Oncol. 2007 May;14(5):1688-93
references.pmid: 17245613
references.citation: J Surg Res. 2002 Apr;103(2):252-9
references.pmid: 11922742
references.citation: J Gastrointest Surg. 2008 Mar;12(3):550-4
references.pmid: 17786527
references.citation: Gut. 1996 Apr;38(4):525-7
references.pmid: 8707081
references.citation: Hepatogastroenterology. 2000 Sep-Oct;47(35):1489-94
references.pmid: 11100384
references.citation: J Exp Clin Cancer Res. 2004 Jun;23(2):215-24
references.pmid: 15354405
references.citation: Ann Surg. 1998 Oct;228(4):449-61
references.pmid: 9790335
references.citation: Gastric Cancer. 1998 Mar;1(2):125-133
references.pmid: 11957056
references.citation: Ann Surg Oncol. 2002 Nov;9(9):894-900
references.pmid: 12417512
references.citation: Br J Cancer. 1999 Mar;79(9-10):1522-30
references.pmid: 10188901
references.citation: World J Surg. 1987 Aug;11(4):406-11
references.pmid: 3630184
references.citation: J Surg Oncol. 2000 May;74(1):30-2
references.pmid: 10861605
references.citation: Cancer. 2000 Apr 15;88(8):1796-800
references.pmid: 10760754
references.citation: J Clin Oncol. 2005 Oct 1;23(28):7114-24
references.pmid: 16192595
references.citation: Cancer. 2002 Jun 1;94(11):2862-6
references.pmid: 12115373
references.citation: Eur J Surg Oncol. 2002 Jun;28(4):455-61
references.pmid: 12099659
references.citation: Gastric Cancer. 2004;7(4):254-9
references.pmid: 15616774
references.citation: Br J Cancer. 2004 May 4;90(9):1727-32
references.pmid: 15150592
references.citation: Ann Surg Oncol. 2007 Feb;14(2):317-28
references.pmid: 17094022
references.citation: Eur J Surg Oncol. 2002 Jun;28(4):406-12
references.pmid: 12099651
references.citation: World J Gastroenterol. 2007 Aug 14;13(30):4122-5
references.pmid: 17696234
references.citation: Gastric Cancer. 1998 Dec;1(1):10-24
references.pmid: 11957040